Effectiveness of a Home-Based Cognitive Rehabilitation Program in Patients With MCI
Effectiveness of a Home-Based Cognitive Rehabilitation Program Driven by a Tablet Application in Patients With Mild Cognitive Impairment
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Yangsan
-
Gyeongsang, Yangsan, Korea, Republic of, 50610
- Pusan National University Yangsan Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women over the age of 55
- Those who have visual and auditory abilities without difficulties in conducting this research
- Those with K-MMSE (Korean-Mini Mental State Examination) score of 24 or higher and 16≤K-MoCA score<23
- In the case of patients taking dementia treatment, those who have the same treatment regimen and dose for 3 months or more from the screening date
- A person who can understand and respond to the questionnaire questions.
- A person who voluntarily decided to participate in this study and gave written consent to the informed consent form
Exclusion Criteria:
- Those with a history of alcohol or drug abuse,
- Those with a past history of uniaxial psychiatric disorders, including intellectual disability, schizophrenia, alcoholism, and bipolar disorder
- A person who is unable to communicate
- Those who show all neurological symptoms that cause cognitive decline, such as Parkinson's disease, cerebral hemorrhage, brain tumor, and hydrocephalus
- Those with a record of being unconscious for more than 1 hour due to head trauma or mild repetitive head trauma
- Those with symptoms of depression that may affect cognitive function
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Home based cognitive rehabilitation program
The intervention was conducted for 30 minutes each time, 3 times a week for 8 weeks, a total of 24 times.
|
The home based cognitive rehabilitation program intervention was conducted for 30 minutes each time, 3 times a week for 8 weeks, a total of 24 times.
|
|
No Intervention: No intervention
In the control group, natural cognitive changes with the passage of time were observed.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of the Korean-Montreal cognitive assessment(MoCA) score
Time Frame: Baseline and Week 8
|
It is a tool to evaluate overall cognitive function.
Possible scores range from 0(lowest cognitive function) to 30 (highest cognitive function).
Change = Paired t-test with baseline score and week 8 score.
|
Baseline and Week 8
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of the semantic verbal emory test (SVLT) score
Time Frame: Baseline and Week 8
|
It is a tool to evaluate language memory function.
Possible scores range from 0(lowest) to 36 (highest).
Change = Paired t-test with baseline score and week 8 score.
|
Baseline and Week 8
|
|
Change of the Digit Span Test (DST) score
Time Frame: Baseline and Week 8
|
It is a tool to evaluate number memorization and attention.
Possible scores range from 0(lowest) to 9 (highest).
Change = Paired t-test with baseline score and week 8 score.
|
Baseline and Week 8
|
|
Change of the category word fluency test (CWFT) score
Time Frame: Baseline and Week 8
|
It is a tool to evaluate executive function.
In one minute, the speak words of the given category is performed, and the number of words spoken within the time is evaluated as a score.
Change = Paired t-test with baseline score and week 8 score.
|
Baseline and Week 8
|
|
Change of the phonemic word fluency test (PWFT) score
Time Frame: Baseline and Week 8
|
It is a tool to evaluate executive function.
In one minute, the speak words that start with a given phoneme is performed, and the number of words spoken within the time is evaluated as a score.
Change = Paired t-test with baseline score and week 8 score.
|
Baseline and Week 8
|
|
Change of the geriatric depression scale (GDS) score
Time Frame: Baseline and Week 8
|
It is a tool to evaluate degree of depression.
Possible scores range from 0(lowest depression) to 21 (highest depression).
Change = Paired t-test with baseline score and week 8 score.
|
Baseline and Week 8
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Young-Il Shin, Pusan National University Yangsan Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 02-2019-018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.